Doravirine accepted for HIV-1 in adults without past or present evidence of resistance to the NNRTI class

Doravirine offers an additional treatment choice in the therapeutic class of NNRTIs for this indication.

Join OnMedica and benefit from:

  • Bitesize CPD and easy to digest content, free for UK-based GPs and specialist doctors
  • High-quality, evidence-based content developed by expert editors and clinicians
  • Articles, quizzes, videos, visual summaries and more
  • Regulatory alerts and round-up of medical journals
  • New content added daily, so you know you’re always up to date

Existing members Sign in